Treatment options in relapsed NLPHL. *Can be considered in patients who had RT alone, rituximab alone, active surveillance, or CMT containing limited amounts of chemotherapy as management strategy at the initial NLPHL diagnosis. ^†Should be considered especially in patients with poor-risk characteristics.